Katherine Wendy Cook

Title: Katherine Wendy Cook: Innovator in Cancer Immunotherapy

Introduction

Katherine Wendy Cook is a prominent inventor based in Oxfordshire, GB. She has made significant contributions to the field of cancer immunotherapy through her innovative research and development of novel epitopes.

Latest Patents

Katherine holds 1 patent related to her work on epitopes containing homocitrulline. This invention focuses on the use of homocitrullinated T cell epitopes as targets for cancer immunotherapy. The patent describes how these modified peptides can serve as vaccines or targets for T cell receptor (TCR) and adoptive T cell transfer therapies. The epitopes have a predicted binding score to MIC class II or class I of less than 30, and they feature at least five consecutive amino acids that form a spiral conformational structure.

Career Highlights

Katherine has established herself as a key figure in her field, working with Scancell Limited, a company dedicated to advancing cancer treatment. Her research has the potential to significantly impact the way cancer is treated, offering new avenues for immunotherapy.

Collaborations

Katherine collaborates with esteemed colleagues such as Wei Xue and Linda Gillian Durrant, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Katherine Wendy Cook's work in developing epitopes for cancer immunotherapy exemplifies her commitment to advancing medical science. Her contributions are paving the way for new therapeutic strategies in the fight against cancer.